Neoadjuvant capecitabine and oxaliplatin (XELOX) with bevacizumab for locally advanced rectal cancer

被引：1
|
作者：
Hasegawa, Junichi
Mizushima, Tsunekazu
Kim, Ho Min
Miyake, Yasuhiro
Takemoto, Hiroyoshi
Tamagawa, Hiroshi
Noura, Shingo
Ohue, Masayuki
Fujii, Makoto
Fujie, Yuichiro
Ota, Hirofumi
Kato, Takeshi
Fukunaga, Mutsumi
Takemasa, Ichiro
Ikeda, Masataka
Yamamoto, Hirofumi
Sekimoto, Mistugu
Nezu, Riichiro
Doki, Yuichiro
Mori, Masaki
机构：
[1] Osaka Rosai Hosp, Dept Surg, Sakai, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan
[3] Minou Municipal Hosp, Dept Surg, Minou, Japan
[4] Kinki Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Dept Surg, Itami, Hyogo, Japan
[5] Osaka Gen Med Ctr, Dept Surg, Osaka, Japan
[6] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan
[7] Osaka Koseinenkin Hosp, Dept Surg, Osaka, Japan
[8] Osaka Saiseikai Senri Hosp, Dept Surg, Suita, Osaka, Japan
[9] Kansai Rosai Hosp, Dept Surg, Amagasaki, Hyogo, Japan
[10] Sakai City Hosp, Sakai, Osaka, Japan
[11] Osaka Natl Hosp, Natl Hosp Org, Dept Surg, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
566
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal Cancer
    Joybari, Ali Yaghobi
    Azadeh, Payam
    Babaei, Siamak
    Kamal, Farnaz Hosseini
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (04) : 1599 - 1605
  • [2] Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer
    Hasegawa, Junichi
    Nishimura, Junichi
    Mizushima, Tsunekazu
    Miyake, Yasuhiro
    Kim, Ho Min
    Takemoto, Hiroyoshi
    Tamagawa, Hroshi
    Noura, Shingo
    Fujii, Makoto
    Fujie, Yujiro
    Kato, Takeshi
    Miwa, Hideaki
    Takemasa, Ichiro
    Ikeda, Masataka
    Yamamoto, Hirofumi
    Sekimoto, Mistugu
    Nezu, Riichiro
    Doki, Yuichiro
    Mori, Masaki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 1079 - 1087
  • [3] Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer
    Junichi Hasegawa
    Junichi Nishimura
    Tsunekazu Mizushima
    Yasuhiro Miyake
    Ho Min Kim
    Hiroyoshi Takemoto
    Hroshi Tamagawa
    Shingo Noura
    Makoto Fujii
    Yujiro Fujie
    Takeshi Kato
    Hideaki Miwa
    Ichiro Takemasa
    Masataka Ikeda
    Hirofumi Yamamoto
    Mistugu Sekimoto
    Riichiro Nezu
    Yuichiro Doki
    Masaki Mori
    [J]. Cancer Chemotherapy and Pharmacology, 2014, 73 : 1079 - 1087
  • [4] Neoadjuvant Radiochemotherapy with Capecitabine and Oxaliplatin plus bevacizumab in locally advanced Rectal Cancer - Results of a phase II study
    Dellas, K.
    Hoehler, T.
    Riesenbeck, D.
    Reese, T.
    Wuerschtnidt, F.
    Engel, E.
    Roedel, C.
    Wagner, W.
    Richter, M.
    Dunst, J.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 51 - 51
  • [5] NEOADJUVANT CHEMOTHERAPY CAPECITABINE AND OXALIPLATIN (XELOX) COMBINED WITH BEVACIZUMAB FOR HIGH-RISK LOCALIZED RECTAL CANCER
    Takeshi, Kato
    Junichi, Hasegawa
    Tsunekazu, Mizushima
    Ho, Kim
    Yasuhiro, Miyake
    Taishi, Hata
    Junichi, Nishimura
    Kazumasa, Ikenaga
    Hiroyoshi, Takemoto
    Hiroshi, Tamagawa
    Shingo, Noura
    Masayuki, Ohue
    Kouhei, Murata
    Yuichiro, Fujie
    Mutsumi, Fukunaga
    Ichirou, Takemasa
    Masataka, Ikeda
    Hirofumi, Yamamoto
    Mistugu, Sekimoto
    Riichirou, Nezu
    Yuichiro, Doki
    Masaki, Mori
    [J]. ANNALS OF ONCOLOGY, 2014, 25 : 95 - 95
  • [6] NEOADJUVANT IRRADIATION IN LOCALLY ADVANCED RECTAL CANCER WITH SIMULTANEOUS ADMINISTRATION OF CAPECITABINE AND OXALIPLATIN
    Winkler, J.
    Zipp, L.
    Knoblich, J.
    Zimmermann, F.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (12) : 741 - 741
  • [7] Triweekly XELOX Versus Single Capecitabine Concomitant with Neoadjuvant Radiotherapy for Locally Advanced Rectal Cancer
    Li, A.
    Xu, B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E658 - E658
  • [8] PHASE II TRIAL OF NEOADJUVANT BEVACIZUMAB, CAPECITABINE, AND RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER
    Crane, Christopher H.
    Eng, Cathy
    Feig, Barry W.
    Das, Prajnan
    Skibber, John M.
    Chang, George J.
    Wolff, Robert A.
    Krishnan, Sunil
    Hamilton, Stanley
    Janjan, Nora A.
    Maru, Dipen M.
    Ellis, Lee M.
    Rodriguez-Bigas, Miguel A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 824 - 830
  • [9] Phase II Trial of Neoadjuvant Chemotherapy with XELOX plus Bevacizumab for Locally Advanced Rectal Cancer
    Uehara, Keisuke
    Ishiguro, Seiji
    Sakamoto, Eiji
    Maeda, Atsuyuki
    Inoue, Masaya
    Tojima, Yuichiro
    Kobayashi, Satoshi
    Omiya, Naoki
    Ishizuka, Naoki
    Nakao, Akimasa
    Goto, Hidemi
    Nagino, Masato
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 1041 - 1044
  • [10] Phase II Trial of Neoadjuvant Oxaliplatin and Capecitabine (XELOX) and Bevacizumab Without Radiotherapy for Poor-risk Rectal Cancer
    Uehara, K.
    Hiramatsu, K.
    Maeda, A.
    Sakamoto, E.
    Inoue, M.
    Kobayashi, S.
    Tojima, Y.
    Yoshioka, Y.
    Nakayama, G.
    Ohmiya, N.
    Kodera, Y.
    Goto, H.
    Nagino, M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S12 - S13
12345